MIR-744 enhances type i interferon signaling pathway by targeting PTP1B in primary human renal mesangial cells

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhang, Xiaoyan ^a   Han, Xiao ^a   Tang, Yuanjia ^a   Wu, Yanfang ^a   Qu, Bo ^a   Shen, Nan ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERFERON; MICRORNA; MIRN744 MICRORNA, HUMAN; PROTEIN TYROSINE PHOSPHATASE 1B; PTPN1 PROTEIN, HUMAN;

BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFLAMMATION; INNATE IMMUNITY; KIDNEY; MESANGIUM CELL; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION;

CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERFERON TYPE I; KIDNEY; MESANGIAL CELLS; MICRORNAS; PRIMARY CELL CULTURE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; SIGNAL TRANSDUCTION;

EID: 84939191865     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12987     Document Type: Article

References (58)

1. Hawkins, N. J., Wakefield, D. & Charlesworth, J. A. The role of mesangial cells in glomerular pathology. Pathology 22, 24-32 (1990).
2. Radeke, H. & Resch, K. The inflammatory function of renal glomerular mesangial cells and their interaction with the cellular immune system. Clin Investig 70, 825-842 (1992).
3. Veis, J., Yamashita, W., Liu, Y. & Ooi, B. The biology of mesangial cells in glomerulonephritis. Proc Soc Exp Biol Med 195, 160-167 (1990).
4. Flur, K. et al. Viral RNA induces type I interferon-dependent cytokine release and cell death in mesangial cells via melanomadifferentiation-associated gene-5: Implications for viral infection-associated glomerulonephritis. Am J Physiol 175, 2014-2022 (2009).
5. Chan, T.-M., Leung, J. K.-H., Ho, S. K.-N. & Yung, S. Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus. J Am Soc Nephrol 13, 1219-1229 (2002).
6. Barratt, J., Smith, A. C., Molyneux, K. & Feehally, J. Immunopathologenesis of IgAN. 427-443 (Springer, New York, 2007).
7. Campbell, S. et al. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells. J Immunol 176, 1889-1898 (2006).
8. Moura, I. C. et al. The glomerular response to IgA deposition in IgA nephropathy. 88-95 (Elsevier, 2008).
9. Patole, P. S. et al. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J Am Soc Nephrol 16, 1326-1338 (2005).
10. Seret, G., Le Meur, Y., Renaudineau, Y. & Youinou, P. Mesangial cell-specific antibodies are central to the pathogenesis of lupus nephritis. Clin Dev Immunol 2012 (2011).
11. Cash, H. et al. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. J Rheumatol 37, 60-70 (2010).
12. Kiberd, B. A. Interleukin-6 receptor blockage ameliorates murine lupus nephritis. J Am Soc Nephrol 4, 58-61 (1993).
13. Liang, B., Gardner, D. B., Griswold, D. E., Bugelski, P. J. & Song, X. Y. R. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus. Immunology 119, 296-305 (2006).
14. Suematsu, S. et al. Generation of plasmacytomas with the chromosomal translocation t (12; 15) in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 89, 232-235 (1992).
15. Crow, M. Type I interferon in systemic lupus erythematosus. 359-386 (Springer, New York, 2007).
16. Nacionales, D. C. et al. Deficiency of the type I interferon receptor protects mice from experimental lupus. Arthritis Rheum 56, 3770-3783 (2007).
17. He, L. & Hannon, G. J. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5, 522-531 (2004).
18. Morin, R. D. et al. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res 18, 610-621 (2008).
19. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
20. Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (2005).
21. Hou, J. et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 183, 2150-2158 (2009).
22. Sheedy, F. J. et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11, 141-147 (2010).
23. Curtale, G. et al. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 115, 265-273 (2010).
24. Du, C. et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 10, 1252-1259 (2009).
25. Ebert, P. J., Jiang, S., Xie, J., Li, Q.-J. & Davis, M. M. An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a. Nat Immunol 10, 1162-1169 (2009).
26. Baechler, E. C. et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 100, 2610-2615 (2003).
27. Bennett, L. et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197, 711-723 (2003).
28. Dall'Era, M. C., Cardarelli, P. M., Preston, B. T., Witte, A. & Davis, J. C. Type I interferon correlates with serological and clinical manifestations of SLE. Ann Rheum Dis 64, 1692-1697 (2005).
29. Dai, Y. et al. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 29, 749-754 (2009).
30. Berezikov, E. et al. Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis. Genome Res 16, 1289-1298 (2006).
31. Chen, Y. Q. et al. Abated microRNA-195 expression protected mesangial cells from apoptosis in early diabetic renal injury in mice. J Nephrol 25, 566 (2012).
32. Kenner, K. A., Anyanwu, E., Olefsky, J. M. & Kusari, J. Protein-tyrosine phosphatase 1B is a negative regulator of insulin-and insulin-like growth factor-I-stimulated signaling. J Biol Chem 271, 19810-19816 (1996).
33. Gauzzi, M. C. et al. Interferon-α-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. J Biol Chem 271, 20494-20500 (1996).
34. Rani, M. S. et al. Catalytically active TYK2 is essential for interferon-β-mediated phosphorylation of STAT3 and interferon-α receptor-1 (IFNAR-1) but not for activation of phosphoinositol 3-kinase. J Biol Chem 274, 32507-32511 (1999).
35. Weichselbaum, R. R. et al. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci USA 105, 18490-18495 (2008).
36. Du, Z. et al. Non-conventional signal transduction by type 1 interferons: The NF-κ B pathway. J Cell Biochem 102, 1087-1094 (2007).
37. Platanias, L. C. Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat Rev Immunol 5, 375-386 (2005).
38. Wong, C., Wang, C., Ip, W., Tian, Y. & Lam, C. Role of p38 MAPK and NF-kB for chemokine release in coculture of human eosinophils and bronchial epithelial cells. Clin Exp Immunol 139, 90-100 (2005).
39. Wong, C. K., Cheung, P. F., Ip, W. K. & Lam, C. W. Interleukin-25-Induced Chemokines and Interleukin-6 Release from Eosinophils Is Mediated by p38 Mitogen-Activated Protein Kinase, c-Jun N-Terminal Kinase, and Nuclear Factor-κ B. Am J Respir Cell Mol Biol 33, 186-194 (2005).
40. Nagajyothi, F. et al. Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype. Obesity 16, 1992-1997 (2008).
41. Wong, C.-K. et al. Activation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: implications in atopic dermatitis. PloS one 7, e29815 (2012).
42. Meshkani, R. & Adeli, K. Mechanisms linking the metabolic syndrome and cardiovascular disease: role of hepatic insulin resistance. J Tehran Heart Cent 4, 77-84 (2009).
43. Myers, M. P. et al. TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J Biol Chem 276, 47771-47774 (2001).
44. Lund, I., Hansen, J., Andersen, H., Moller, N. & Billestrup, N. Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling. J Mol Endocrinol 34, 339-351 (2005).
45. Nasimian, A., Taheripak, G., Gorgani-Firuzjaee, S., Sadeghi, A. & Meshkani, R. Protein tyrosine phosphatase 1B (PTP1B) modulates palmitate-induced cytokine production in macrophage cells. Inflamm Res 62, 239-246 (2013).
46. Ortiz, C. et al. Protein-tyrosine phosphatase 1B (PTP1B) deficiency confers resistance to transforming growth factor-β (TGF-β )-induced suppressor effects in hepatocytes. J Biol Chem 287, 15263-15274 (2012).
47. Traves, P. et al. Pivotal role of protein tyrosine phosphatase 1B (PTP1B) in the macrophage response to pro-inflammatory and anti-inflammatory challenge. Cell Death Dis 5, e1125 (2014).
48. Schlondorff, D. & Banas, B. The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 20, 1179-1187 (2009).
49. Sterzel, R. B., Schulze-Lohoff, E. & Marx, M. Cytokines and mesangial cells. Kidney Int 39, S26-31 (1993).
50. Tang, Y. et al. MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 60, 1065-1075 (2009).
51. Zhao, X. et al. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum 62, 3425-3435 (2010).
52. Feng, X. et al. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum 54, 2951-2962 (2006).
53. Martin, J. et al. Post-transcriptional regulation of transforming growth factor beta-1 by microRNA-744. PLoS One 6, e25044 (2011).
54. Ho, H. H. & Ivashkiv, L. B. Role of STAT3 in type I interferon responses Negative regulation of STAT1-dependent inflammatory gene activation. J Biol Chem 281, 14111-14118 (2006).
55. Nakagawa, R. et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 17, 677-687 (2002).
56. Tisserand, J. et al. Tripartite motif 24 (Trim24/Tif1α ) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor α (Rarα ) inhibition. J Biol Chem 286, 33369-33379 (2011).
57. Baccala, R., Hoebe, K., Kono, D. H., Beutler, B. & Theofilopoulos, A. N. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 13, 543-551 (2007).
58. Taganov, K. D., Boldin, M. P. & Baltimore, D. MicroRNAs and immunity: tiny players in a big field. Immunity 26, 133-137 (2007).